MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK

被引：0
|
作者：
Brennan, A. [1 ]
Bansback, N. [1 ]
Conway, P. [2 ]
Reynolds, A. [2 ]
机构：
[1] Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[2] Wyeth Labs, Maidenhead, Berks, England
来源：
RHEUMATOLOGY | 2002年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of etanercept monotherapy versus infliximab plus methotrexate in the treatment of rheumatoid arthritis.
    Malone, DC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S322 - S322
  • [42] THE COST-EFFECTIVENESS OF COCHLEAR IMPLANTS IN UK ADULTS
    Cutler, H.
    Gumbie, M.
    Olin, E.
    Parkinson, B.
    Bowman, R.
    Quadri, H.
    Gonzalo, F.
    [J]. VALUE IN HEALTH, 2019, 22 : S886 - S886
  • [43] MODELLING COST-EFFECTIVENESS OF BIOLOGIC STRATEGIES FOR THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN FINLAND
    Puolakka, Kari
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 : 34 - 34
  • [44] Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France
    Saraux, Alain
    Gossec, Laure
    Goupille, Philippe
    Bregman, Bruno
    Boccard, Eric
    Dupont, Danielle
    Beresniak, Ariel
    [J]. RHEUMATOLOGY, 2010, 49 (04) : 733 - 740
  • [45] MODELLING THE COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR RHEUMATOID ARTHRITIS IN ENGLAND AND WALES
    Righetti, C.
    Lebmeier, M.
    Pennington, B.
    Brereton, N. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A578 - A579
  • [46] Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea
    Park, Sun-Kyeong
    Park, Seung-Hoo
    Lee, Min-Young
    Park, Ji-Hyun
    Jeong, Jae-Hong
    Lee, Eui-Kyung
    [J]. CLINICAL THERAPEUTICS, 2016, 37 (11) : 2430 - 2446
  • [47] COST-EFFECTIVENESS ANALYSIS OF GOLIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Desai, R. J.
    Rao, J.
    Biddle, A. K.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
  • [48] THE COST-EFFECTIVENESS OF ALTERNATIVE TREATMENT SEQUENCES IN RHEUMATOID ARTHRITIS
    Trueman, D.
    Bird, A.
    Mumby-Croft, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
  • [49] Cost-effectiveness of lifelong infliximab for rheumatoid arthritis in Portugal
    Wong, JB
    Branco, JC
    Cobrado, N
    Nero, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 360 - 360
  • [50] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis RESPONSE
    Boers, Maarten
    [J]. ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 334 - 334
12345